相关实验视频

Updated: Jan 14, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

与降低血元基因组测序相关的直接成本节约

Caitlin Naureckas Li^1,2, Neil Jordan¹, Shannon Haymond^1,3

¹https://ror.org/000e0be47Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Infection control and hospital epidemiology

|October 21, 2025

概括

实施一种传染病批准流程,用于血甲基因组下一代测序,大大降低了医院费用. 这种有针对性的方法通过优化实验室支出,实现了大幅度的年度节约.

科学领域:

临床诊断临床诊断临床诊断
基因组医学是一种基因组医学.

背景情况:

医院血基因组下一代测序 (mNGS) 的利用率超过了同行基准.
对mNGS的高利用率可能表明测试订单实践不足于最佳.

研究的目的:

评估传染病 (ID) 审批流程对mNGS测试利用和相关成本的影响.
确定实施高级分子诊断的管理干预措施的财务效益.

主要方法:

实施了一项前性干预措施,要求在血元基因组下一代测序采集之前批准传染病.
根据实验室测试费用预计的减少,计算了成本节约.

主要成果:

预计这项干预将导致每年直接节省成本,从79,505美元到84,057美元.
节约主要是由于与减少mNGS测试相关的实验室成本的降低.

结论:

实施以传染病为主导的批准流程是控制与mNGS等先进分子诊断相关的成本的有效策略.
这种管理方法显示出显著的财务效益,并优化了医疗保健机构的资源配置.

更多相关视频

Sequencing of mRNA from Whole Blood using Nanopore Sequencing

Sequencing of mRNA from Whole Blood using Nanopore Sequencing

Published on: June 3, 2019

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons

Published on: August 29, 2014

相关概念视频

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....